Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Article
  • Access
  • Open access

Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?

  • A. DIOUF (a1) (a2) (a3), H. TROTTIER (a2) (a3), T. J. YOUBONG (a1), N. F. NGOM-GUÉYE (a4), O. NDIAYE (a1), A. SECK (a5), D. SARR (a6), S. DIOP (a7), M. SEYDI (a1), S. MBOUP (a8), V. K. NGUYEN (a2) (a9) and A. JAYE (a10)...

Summary

We examined the association between a history of smallpox vaccination and immune activation (IA) in a population of antiretroviral therapy-naïve people living with HIV (PLHIV). A cross-sectional study was conducted in Senegal from July 2015 to March 2017. Smallpox vaccination was ascertained by the presence of smallpox vaccine scar and IA by the plasma level of β-2-microglobulin (β2m). The association was analysed using logistic regression and linear regression models. The study population comprised 101 PLHIV born before 1980 with a median age of 47 years (interquartile range (IQR) = 42–55); 57·4% were women. Smallpox vaccine scar was present in 65·3% and the median β2m level was 2·59 mg/l (IQR = 2·06–3·86). After adjustment, the presence of smallpox vaccine scar was not associated with a β2m level ⩾2·59 mg/l (adjusted odds ratio 0·94; 95% confidence interval 0·32–2·77). This result was confirmed by the linear regression model. Our study does not find any association between the presence of smallpox vaccine scar and the β2m level and does not support any association between a previous smallpox vaccination and HIV disease progression. In this study, IA is not a significant determinant of the reported non-targeted effect of smallpox vaccination in PLHIV.

  • View HTML

      • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?
      Available formats
      ×

Copyright

COPYRIGHT: © Cambridge University Press 2017
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

*Author for correspondence: Dr A. Diouf, Department of Social and Preventive Medicine, Université de Montréal, CHU Sainte-Justine Research Center, 3175 Côte Ste-Catherine, Room B.17·002, Montreal, Qc, Canada. (Email: a.diouf@umontreal.ca)

References

Hide All
1. The Independent Advisory Group on Public Health Implications of Synthetic Biology Technology Related to Smallpox. A report to the Director-General of WHO. WHO, Geneva, Switzerland 29–30 June 2015.
2. WHO Advisory Committee on Variola Virus Research. Report of the Eighteenth Meeting. WHO, Geneva, Switzerland 2–3 November 2016.
3. Greenberg, RN, et al. Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. Journal of Infectious Diseases 2013; 207: 749–758.
4. Weinstein, RS, et al. Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with vaccinia virus. BMC Immunology 2010; 11: 23.
5. Weinstein, RS, Weinstein, MM, Alibek, K, Inventors; Weinstein, RS, Weinstein, MM, Alibek, K Assignees. Compositions and methods for treating or preventing HIV infection. United States patent US20100189747 A1, 2010 July 29.
6. Jensen, ML, et al. Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau. PLoS ONE 2006; 1: e101.
7. Aaby, P, et al. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine 2006; 24: 5718–5725.
8. Miedema, F, et al. Immune activation and collateral damage in AIDS pathogenesis. Frontiers in Immunology 2013; 4: 298.
9. Netea, MG, Quintin, J, van der Meer, JW. Trained immunity: a memory for innate host defense. Cell Host & Microbe 2011; 9: 355–361.
10. Demkowicz, WE Jr., et al. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. Journal of Virology 1996; 70: 2627–2631.
11. Crotty, S, et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. The Journal of Immunology 2003; 171: 4969–4973.
12. Taub, DD, et al. Immunity from smallpox vaccine persists for decades: a longitudinal study. The American Journal of Medicine 2008; 121: 1058–1064.
13. Organisation Mondiale de la Santé. Analyse scientifique de la recherche sur le virus variolique, 1999–2010. OMS, Décembre 2010.
14. Agence Nationale de la Statistique et de la Démographie (ANSD). Enquête Démographique et de Santé à Indicateurs Multiples Sénégal (EDS-MICS) 2010–2011. Février 2012, Dakar, Sénégal.
15.République du Sénégal, Conseil National de Lutte contre le Sida. Rapport Enquête combinée chez les HSH. Dakar, Sénégal, 2014.
16. Wade, AS, et al. Reduction in risk-taking behaviors among MSM in Senegal between 2004 and 2007 and prevalence of HIV and other STIs. ELIHoS Project, ANRS 12139. AIDS Care 2010; 22: 409–414.
17. Leprêtre, A, et al. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study. Journal of the International AIDS Society 2015; 18: 19888.
18. Who International Laboratory for Biological Standards. The International Standard for beta 2 microglobulin. WHO, Medicine and Healthcare Products Regulatory Agency, 1996.
19. Fine, PE, Ponnighaus, JM, Maine, N. The distribution and implications of BCG scars in northern Malawi. Bulletin of the World Health Organization 1989; 67: 35–42.
20. Poulsen, AG, et al. Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. Scandinavian Journal of Infectious Diseases 2000; 32: 169–175.
21. Gottlieb, MS, et al. Morbidity and Mortality Weekly Report. 1981, Volume 30: pp. 250–252.
22. Faria, NR, et al. HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations. Science 2014; 346: 56–61.
23. Kan, VL, et al. Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection. AIDS 2007; 21: 521–524.
24. Rieckmann, A, et al. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971–2010. International Journal of Epidemiology 2017; 46: 695–705.
25. Sørup, S, et al. Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. International Journal of Epidemiology 2011; 40: 955–963.
26. Hammarlund, E, et al. Antiviral immunity following smallpox virus infection: a case-control study. Journal of Virology 2010; 84: 12754–12760.
27. Muraille, E. The unspecific side of acquired immunity against infectious disease: causes and consequences. Frontiers in Microbiology 2016; 6: 1525.
28. Gilat, T, et al. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scandinavian Journal of Gastroenterology 1987; 22: 1009–1024.
29. Kurtzke, JF, et al. Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurologica Scandinavica 1997; 96: 149–157.
30. Pfahlberg, A, et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. Journal of Investigative Dermatology 2002; 119: 570–575.
31. Kolmel, KF, et al. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. A European organization for research and treatment of cancer cohort study on 542 patients. European Journal of Cancer 2005; 41: 118–125.
32. Bager, P, et al. Smallpox vaccination and risk of atopy and asthma. Journal of Allergy and Clinical Immunology 2003; 111: 1127–1131.
33. Blom, L, et al. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 1991; 34: 176–181.
34. Classen, J, Classen, DC. Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity 1999; 31: 43–45.
35. Mayr, A. Taking advantage of the positive side-effects of smallpox vaccination. Journal of Veterinary Medicine B Infectious Disease and Veterinary Public Health 2004; 51: 199–201.
36. Crum-Cianflone, NF, Sullivan, E. Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II. Infectious diseases and therapy 2017 Aug 5.
37. Bray, M, Buller, M. Looking back at smallpox. Clinical Infectious Diseases 2004; 38: 882–889.

Keywords

Type Description Title
WORD
Supplementary materials

Diouf et al supplementary material
Tables 5-7

 Word (36 KB)
36 KB
  • Access
  • Open access

Does smallpox vaccination modify HIV disease progression among ART-naive people living with HIV in Africa?

  • A. DIOUF (a1) (a2) (a3), H. TROTTIER (a2) (a3), T. J. YOUBONG (a1), N. F. NGOM-GUÉYE (a4), O. NDIAYE (a1), A. SECK (a5), D. SARR (a6), S. DIOP (a7), M. SEYDI (a1), S. MBOUP (a8), V. K. NGUYEN (a2) (a9) and A. JAYE (a10)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed